Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · IEX Real-Time Price · USD
5.83
+0.03 (0.52%)
May 31, 2024, 4:00 PM EDT - Market closed

Foghorn Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018
Cash & Equivalents
82.0453.92102.8794.5317.26
Upgrade
Short-Term Investments
153.72293.5853.1592.980
Upgrade
Cash & Cash Equivalents
235.77347.51156.02187.517.26
Upgrade
Cash Growth
-32.16%122.73%-16.79%986.66%-57.48%
Upgrade
Receivables
0030000
Upgrade
Other Current Assets
4.423.893.543.18-0.37
Upgrade
Total Current Assets
240.18351.4459.56190.6916.89
Upgrade
Property, Plant & Equipment
42.9149.456.0862.333.71
Upgrade
Other Long-Term Assets
2.824.094.132.581.74
Upgrade
Total Long-Term Assets
45.7453.4860.2164.915.46
Upgrade
Total Assets
285.92404.88519.77255.5922.34
Upgrade
Accounts Payable
6.265.413.823.683.44
Upgrade
Deferred Revenue
302.67336.82351.0514.570
Upgrade
Current Debt
8.525.976.993.985.51
Upgrade
Other Current Liabilities
-259.01-293-313.17-3.393.7
Upgrade
Total Current Liabilities
58.4455.2148.6918.8512.65
Upgrade
Long-Term Debt
36.5645.5451.3478.0211.12
Upgrade
Other Long-Term Liabilities
268.12304.03322.8712.550.05
Upgrade
Total Long-Term Liabilities
304.67349.57374.2190.5611.16
Upgrade
Total Liabilities
363.11404.77422.9109.4123.81
Upgrade
Total Debt
45.0751.5158.338216.63
Upgrade
Debt Growth
-12.49%-11.70%-28.86%393.09%136.58%
Upgrade
Retained Earnings
-471.56-373.14-264.26-162.94-94.14
Upgrade
Comprehensive Income
-0.83-3.99-0.01-0.010
Upgrade
Shareholders' Equity
-77.190.1196.87146.19-88.02
Upgrade
Net Cash / Debt
190.6929697.69105.510.63
Upgrade
Net Cash / Debt Growth
-35.58%203.00%-7.41%16754.15%-98.13%
Upgrade
Net Cash Per Share
4.547.122.639.550.15
Upgrade
Working Capital
181.75296.19410.87171.844.23
Upgrade
Book Value Per Share
-1.840.002.6113.23-21.00
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).